RSSL, a pharmaceutical contract research organisation, has announced plans to launch its new Innovation Hub.
RSSL’s Innovation Hub will be a supportive ecosystem for early-stage biotech companies, providing a range of tailored services to help them navigate the journey from concept to commercialisation.
By working with RSSL, clients can access on-site commercial laboratory space, with equipment and instrumentation available for use.
They will also be able to benefit from RSSL’s expertise, project management experience and network of industry contacts to support their product development.
The platform comprises four different models that will allow clients to collaborate with RSSL on a flexible basis depending on their needs.
For each model, clients will have a dedicated account manager to oversee operations and serve as their main point of contact. The four models include:
The launch of RSSL’s Innovation Hub is a key component of its ambitious long-term expansion strategy that will see the company implement several initiatives to increase its operational capacity and breadth of services.
These initiatives will build on the recent opening of its new analytical testing facility, which has added 26,000 sqft of working laboratory space.
They will also play a crucial role in supporting its plans to double the number of members within its scientific team over the next three years.
Jacinta George, Managing Director, RSSL said: “Our goal is to drive vital research and support innovation across the entire life science sector. With the new Innovation Hub, we are providing start-ups, spin-outs, and other early-stage biotech organisations with dedicated laboratory space and specialist expertise to fast-track their development programmes.”
